These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18413687)

  • 41. Drug-drug interaction study to assess the effects of multiple-dose pitavastatin on steady-state warfarin in healthy adult volunteers.
    Inagaki Y; Hunt T; Arana B; Gosho M; Morgan R
    J Clin Pharmacol; 2011 Sep; 51(9):1302-9. PubMed ID: 21228405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol-warfarin interaction.
    Dumo PA; Kielbasa LA
    Pharmacotherapy; 2006 Nov; 26(11):1654-7. PubMed ID: 17064212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse reaction reporting of interaction between warfarin and fluoroquinolones.
    Jolson HM; Tanner LA; Green L; Grasela TH
    Arch Intern Med; 1991 May; 151(5):1003-4. PubMed ID: 1842668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction.
    Arnold LM; Nissen LR; Ng TM
    Pharmacotherapy; 2005 Jun; 25(6):904-7. PubMed ID: 15927911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
    Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
    Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moxifloxacin-warfarin interaction.
    Yew KL; Lee WC
    Med J Malaysia; 2012 Aug; 67(4):420-1. PubMed ID: 23082454
    [No Abstract]   [Full Text] [Related]  

  • 50. Systematic overview of warfarin and its drug and food interactions.
    Holbrook AM; Pereira JA; Labiris R; McDonald H; Douketis JD; Crowther M; Wells PS
    Arch Intern Med; 2005 May; 165(10):1095-106. PubMed ID: 15911722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics of uniform versus nonuniform warfarin dosages.
    Hameed MS; Nafziger AN; Gartung AM; Bertino JS
    Pharmacotherapy; 2008 Jun; 28(6):707-11. PubMed ID: 18503398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.
    Allen GP; Hankins CD
    J Antimicrob Chemother; 2009 Aug; 64(2):359-63. PubMed ID: 19460783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy.
    Yamreudeewong W; Lower DL; Kilpatrick DM; Enlow AM; Burrows MM; Greenwood MC
    Pharmacotherapy; 2003 Mar; 23(3):333-8. PubMed ID: 12627932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extremely prolonged INR associated with warfarin in combination with both trazodone and omega-3 fatty acids.
    Jalili M; Dehpour AR
    Arch Med Res; 2007 Nov; 38(8):901-4. PubMed ID: 17923275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-drug interactions with fluoroquinolones.
    Marchbanks CR
    Pharmacotherapy; 1993; 13(2 Pt 2):23S-28S. PubMed ID: 8474934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.
    Leung VW; Shalansky SJ; Lo MK; Jadusingh EA
    Ann Pharmacother; 2009 May; 43(5):875-81. PubMed ID: 19401475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
    Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
    Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.